Friday, 16 October 2026European Markets

SELVAAG BOLIG And 2 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Loading stream...

(VIANEWS) - SELVAAG BOLIG (SBO.OL), OKEA (OKEA.OL), LERØY SEAFOOD GP (LSG.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. SELVAAG BOLIG (SBO.OL)

133% sales growth and 10.32% return on equity

Selvaag Bolig ASA, a housing development company, engages in the development, construction, and sale of residential properties in Greater Oslo, Bergen, Stavanger, Trondheim, and Stockholm. The company also offers project management services. Selvaag Bolig ASA was incorporated in 2008 and is headquartered in Oslo, Norway. Selvaag Bolig ASA is a subsidiary of Selvaag AS.

Earnings Per Share

As for profitability, SELVAAG BOLIG has a trailing twelve months EPS of kr2.58.

PE Ratio

SELVAAG BOLIG has a trailing twelve months price to earnings ratio of 9.98. Meaning, the purchaser of the share is investing kr9.98 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.32%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 13.4%, now sitting on 3.14B for the twelve trailing months.

Sales Growth

SELVAAG BOLIG's sales growth is negative 58.1% for the ongoing quarter and 133% for the next.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Aug 15, 2023, the estimated forward annual dividend rate is 3 and the estimated forward annual dividend yield is 11.07%.

More news about SELVAAG BOLIG.

2. OKEA (OKEA.OL)

33.2% sales growth and 32.98% return on equity

OKEA ASA, an oil and gas company, engages in the development and production of oil and gas in the Norwegian continental shelf. The company holds 44.56% interests in Draugen, 12% interests in Gjøa, 9.2385% interests in Ivar Aasen, 6% interests in Nova, and 15% interests in Yme assets. OKEA ASA was incorporated in 2015 and is headquartered in Trondheim, Norway.

Earnings Per Share

As for profitability, OKEA has a trailing twelve months EPS of kr6.27.

PE Ratio

OKEA has a trailing twelve months price to earnings ratio of 6.14. Meaning, the purchaser of the share is investing kr6.14 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.98%.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is a negative 76.3% and a negative 56.2%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.4%, now sitting on 8.18B for the twelve trailing months.

More news about OKEA.

3. LERØY SEAFOOD GP (LSG.OL)

12.1% sales growth and 3.73% return on equity

Lerøy Seafood Group ASA produces, processes, markets, sells, and distributes seafood products worldwide. It operates in three segments: Wildcatch; Farming; and Value-Added Processing, Sales and Distribution. The company offers smoked and gravad salmon, and trout products; farmed and wild catch whole fishes; fillets and portions; ready-to-eat and ready-to-cook products; fish blocks and cubes; breaded products; pre-fried fish burgers and patties; crustaceans and molluscs; seaweeds; and other products. Lerøy Seafood Group ASA markets its products primarily under the Norway Seafoods, Arctic Supreme, Fjord trout, Aurora Salmon, Fossen, Sea Eagle, Lerøy, and M?r brands to shops, restaurants, canteens, and hotels. The company was founded in 1899 and is headquartered in Bergen, Norway. Lerøy Seafood Group ASA is a subsidiary of Austevoll Seafood ASA.

Earnings Per Share

As for profitability, LERØY SEAFOOD GP has a trailing twelve months EPS of kr1.02.

PE Ratio

LERØY SEAFOOD GP has a trailing twelve months price to earnings ratio of 42.71. Meaning, the purchaser of the share is investing kr42.71 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.73%.

Sales Growth

LERØY SEAFOOD GP's sales growth is 5.5% for the present quarter and 12.1% for the next.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on May 24, 2023, the estimated forward annual dividend rate is 2.5 and the estimated forward annual dividend yield is 5.71%.

More news about LERØY SEAFOOD GP.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com